Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease

PHASE1TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

April 3, 2013

Conditions
Sickle Cell Disease
Interventions
DRUG

propranolol

Propranolol hydrochloride is a synthetic beta-adrenergic receptor-blocking agent. This will be administered in an open-label single administration to 3 cohorts (10mg, 20mg, and 40mg) of children with sickle cell disease. Patient blood will be evaluated for red cell adhesion and patient data evaluated for safety monitoring.

Trial Locations (1)

33136

University of Miami, Miami

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duke University

OTHER

lead

University of Miami

OTHER